Inferior red nucleus syndrome (Benedikt's syndrome) due to a single intramesencephalic metastasis from a prostatic carcinoma

1981 ◽  
Vol 56 (1-2) ◽  
pp. 59-64 ◽  
Author(s):  
N. Loseke ◽  
J. Retif ◽  
J. Noterman ◽  
J. Flament-Durand
Keyword(s):  
Prostatic Carcinoma ◽  
Red Nucleus ◽  
Benedikt's Syndrome

Prostatic Acid Phosphatase (PAP) Differentiated Ultracytochemically from Lysosomal Acid Phosphate in the Rat with a PAP/Specific Substrate, Phosphorylcholine

1975 ◽  
Vol 33 ◽  
pp. 450-451
Author(s):  
W. Allen Shannon ◽  
José A. Serrano ◽  
Hannah L. Wasserkrug ◽  
Anna A. Serrano ◽  
Arnold M. Seligman
Keyword(s):  
Acid Phosphatase ◽  
Phosphate Buffer ◽  
Prostatic Carcinoma ◽  
Prostatic Acid Phosphatase ◽  
Chemotherapeutic Agents ◽  
Specific Substrate ◽  
Acid Phosphate ◽  
Lysosomal Acid ◽  
Design And Synthesis ◽  
New Chemotherapeutic Agents

During the design and synthesis of new chemotherapeutic agents for prostatic carcinoma based on phosphorylated agents which might be enzyme-activated to cytotoxicity, phosphorylcholine, [(CH3)3+NCH2CH2OPO3Ca]Cl-, has been indicated to be a very specific substrate for prostatic acid phosphatase (PAP). This phenomenon has led to the development of specific histochemical and ultracytochemical methods for PAP using modifications of the Gomori lead method for acid phosphatase. Comparative histochemical results in prostate and kidney of the rat have been published earlier with phosphorylcholine (PC) and β-glycerophosphate (βGP). We now report the ultracytochemical results.Minced tissues were fixed in 3% glutaraldehyde-0.1 M phosphate buffered (pH 7.4) for 1.5 hr and rinsed overnight in several changes of 0.05 M phosphate buffer (pH 7.0) containing 7.5% sucrose. Tissues were incubated 30 min to 2 hr in Gomori acid phosphatase medium (2) containing 0.1 M substrate, either PC or βGP.

Neuroendocrine Differentiation in Prostatic Carcinoma

2003 ◽  
Vol 37 (0) ◽  
pp. 28-36 ◽  
Author(s):  
Jens Hansson ◽  
Per-Anders Abrahamsson
Keyword(s):  
Prostatic Carcinoma ◽  
Neuroendocrine Differentiation

Multiple Squamous Cell Carcinoma Associated with Prostatic Carcinoma

1976 ◽  
Vol 38 (6) ◽  
pp. 924-930 ◽  
Author(s):  
Hidekazu SHINODA ◽  
Kazuki MAEZIMA ◽  
Yasuko ISINO ◽  
Makoto HORI ◽  
Katsutaro NISHIMOTO
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Prostatic Carcinoma

A Receptor Tyrosine Kinase, UFO/Axl, and Other Genes Isolated by a Modified Differential Display PCR Are Overexpressed in Metastatic Prostatic Carcinoma Cell Line DU145

1999 ◽  
Vol 23 (4) ◽  
pp. 325-332 ◽  
Author(s):  
Jacob ◽  
John Kalapurakal ◽  
William R. Davidson ◽  
Geeta Kandpal ◽  
Naomi Dunson ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Cell Line ◽  
Differential Display ◽  
Receptor Tyrosine Kinase ◽  
Prostatic Carcinoma ◽  
Carcinoma Cell ◽  
Carcinoma Cell Line ◽  
Differential Display Pcr

Steroid receptors and hormone responsiveness of human prostatic carcinoma

The Prostate ◽  
1982 ◽  
Vol 3 (5) ◽  
pp. 475-482 ◽  
Author(s):  
G. Concolino ◽  
A. Marocchi ◽  
G. Margiotta ◽  
C. Conti ◽  
F. Di Silverio ◽  
...  
Keyword(s):  
Prostatic Carcinoma ◽  
Steroid Receptors ◽  
Hormone Responsiveness

scholarly journals Fully Automated Targeting Using Nonrigid Image Registration Matches Accuracy and Exceeds Precision of Best Manual Approaches to Subthalamic Deep Brain Stimulation Targeting in Parkinson Disease

Neurosurgery ◽  
2015 ◽  
Vol 76 (6) ◽  
pp. 756-765 ◽  
Author(s):  
Srivatsan Pallavaram ◽  
Pierre-François D'Haese ◽  
Wendell Lake ◽  
Peter E. Konrad ◽  
Benoit M. Dawant ◽  
...  
Keyword(s):  
Deep Brain Stimulation ◽  
Image Registration ◽  
Parkinson Disease ◽  
Brain Stimulation ◽  
Red Nucleus ◽  
Nonrigid Image Registration ◽  
Direct Targeting ◽  
Fully Automatic ◽  
Stn Dbs ◽  
Deep Brain

Abstract BACKGROUND: Finding the optimal location for the implantation of the electrode in deep brain stimulation (DBS) surgery is crucial for maximizing the therapeutic benefit to the patient. Such targeting is challenging for several reasons, including anatomic variability between patients as well as the lack of consensus about the location of the optimal target. OBJECTIVE: To compare the performance of popular manual targeting methods against a fully automatic nonrigid image registration-based approach. METHODS: In 71 Parkinson disease subthalamic nucleus (STN)-DBS implantations, an experienced functional neurosurgeon selected the target manually using 3 different approaches: indirect targeting using standard stereotactic coordinates, direct targeting based on the patient magnetic resonance imaging, and indirect targeting relative to the red nucleus. Targets were also automatically predicted by using a leave-one-out approach to populate the CranialVault atlas with the use of nonrigid image registration. The different targeting methods were compared against the location of the final active contact, determined through iterative clinical programming in each individual patient. RESULTS: Targeting by using standard stereotactic coordinates corresponding to the center of the motor territory of the STN had the largest targeting error (3.69 mm), followed by direct targeting (3.44 mm), average stereotactic coordinates of active contacts from this study (3.02 mm), red nucleus-based targeting (2.75 mm), and nonrigid image registration-based automatic predictions using the CranialVault atlas (2.70 mm). The CranialVault atlas method had statistically smaller variance than all manual approaches. CONCLUSION: Fully automatic targeting based on nonrigid image registration with the use of the CranialVault atlas is as accurate and more precise than popular manual methods for STN-DBS.

Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor κB sites in prostatic carcinoma

2001 ◽  
Vol 32 (1) ◽  
pp. 36-43 ◽  
Author(s):  
Simon Santourlidis ◽  
Ulrich Warskulat ◽  
Andrea R. Florl ◽  
Simone Maas ◽  
Thomas Pulte ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Prostatic Carcinoma ◽  
Tumor Necrosis Factor Receptor ◽  
Gene Promoter ◽  
Nuclear Factor Κb ◽  
Nuclear Factor ◽  
Necrosis Factor

Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice

2021 ◽  
Vol 189 ◽  
pp. 108538
Author(s):  
Hai-Ying Zhang ◽  
Hui Shen ◽  
Ming Gao ◽  
Zegang Ma ◽  
Briana J. Hempel ◽  
...  
Keyword(s):  
Motor Behavior ◽  
Red Nucleus ◽  
Cb2 Receptors ◽  
Cannabinoid Cb2 Receptors

Downstaging of Stage C Prostatic Carcinoma by Inductive Chemo-Hormonal Therapy?

1993 ◽  
Vol 24 (3) ◽  
pp. 337-342 ◽  
Author(s):  
H. Kahla ◽  
J. Köllermann ◽  
M.W. Köllermann ◽  
P. Sprenk ◽  
V. Mühlfait
Keyword(s):  
Hormonal Therapy ◽  
Prostatic Carcinoma
Sign in / Sign up

Export Citation Format

Share Document